Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paracetamol + caffeine vs paracetamol alone in primary dysmenorrhoea
2004-003619-22Phase 3Completed
- Sponsor
- GSK
- Start
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of paracetamol + caffeine and acetaminophen in primary dysmenorrhea (PD) (3 arms), sponsored by GSK. Primary endpoint: Pain relief. Started Jul 2005; status: completed.
02
Drugs
paracetamol + caffeineacetaminophen
03
Conditions
primary dysmenorrhea (PD)
Beyond the preview
Go deeper on 2004-003619-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-003619-22.